释放大自然的潜力和局限性:探索分子向途径和多发性硬化症治疗的安全替代方案 (综述)
相关实验视频
Updated: Aug 14, 2026

10:44
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
Published on: February 22, 2015
10.3K
Sara Fathallah1, Ahmed Abdellatif1,2, Mona Kamal Saadeldin1,2,3
1Biotechnology Program, School of Science and Engineering, American University in Cairo, New Cairo 11835, Egypt.
Medicine international
|September 8, 2023
概括
研究人员正在探索天然化合物作为多发性硬化症 (MS) 的安全治疗方法. 本次审查强调了利用自然的进步.
科学领域:
- 神经科学和药理学 神经科学和药理学
- 自然产品化学 自然产品化学
背景情况:
- 多发性硬化症 (MS) 是一种慢性自身免疫性疾病,影响中枢神经系统.
- 目前的多发性硬化症治疗可以控制症状和恢复,但不能阻止疾病的进展.
- 了解多发性硬化病原体揭示了治疗干预的多个分子标.
研究的目的:
- 审查利用自然分子用于多发性硬化症 (MS) 治疗的最新进展.
- 探索自然衍生化合物的潜力,作为安全有效的MS疗法.
- 通过破译MS相关的分子通路来识别新型治疗剂.
主要方法:
- 关于天然产品和MS的研究的文献综述.
- 对参与多发性硬化病原的分子途径的分析.
- 评估自然存在的分子在MS模型中的治疗潜力.
主要成果:
- 在MS的临床前模型中,许多天然化合物显示出前景.
- 解读分子通路已经揭示了大量潜在的治疗药物.
- 天然产品为现有的多发性硬化症治疗提供了一个潜在的更安全的替代方案.
结论:
- 自然分子是新型多发性硬化症 (MS) 治疗的有希望的途径.
- 对自然资源的进一步研究可能会彻底改变MS治疗.
- 开发安全有效的自然疗法为MS患者提供了新的希望.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

